SPARC mRNA expression more than cut-off in the high-risk group was significantly associated with worse DSS (p=0,0017) and worse PFS (p=0,0039), but with better OS (p=0,0401) in patients with CRC (Figure 2A). The gene discussed is SPARC; the disease is colorectal carcinoma.